P values of all prognostic markers for overall survival as determined by log-rank test and generalized Wilcoxon test
| Prognostic marker . | P, log-rank . | P, generalized Wilcoxon . |
|---|---|---|
| Sex | .62 | .28 |
| Age | .45 | .19 |
| Cytogenetics | .04 | .23 |
| WBCs | .02 | .05 |
| LDH | .01 | .02 |
| Platelets | .66 | .97 |
| CXCR4, A/B/C, MFIR | .01 | .02 |
| CXCR4, A/B + C, MFIR | .00 | .01 |
| Prognostic marker . | P, log-rank . | P, generalized Wilcoxon . |
|---|---|---|
| Sex | .62 | .28 |
| Age | .45 | .19 |
| Cytogenetics | .04 | .23 |
| WBCs | .02 | .05 |
| LDH | .01 | .02 |
| Platelets | .66 | .97 |
| CXCR4, A/B/C, MFIR | .01 | .02 |
| CXCR4, A/B + C, MFIR | .00 | .01 |
In this analysis, the impact of CXCR4 expression on overall survival was analyzed for patients with low (group A), intermediate (group B), or high (group C) CXCR4 expression. In addition, we compared patients with low CXCR4 expression to patients with intermediate and high expression (B + C, bottom row).